Coeptis Therapeutics Holdings, Inc. announced on January 7, 2025, the initial rollout and first customer adoptions of its recently introduced NexGenAI Affiliates Network platform. The company has secured five new clients who will leverage the platform's AI-driven marketing solutions. This early engagement signals the immediate market opportunity for the innovative technology.
The new Managed Services Agreements are valued at $1.25 million, with an anticipated revenue stream of $450,000 supporting recurring monthly cash revenues. These figures represent the initial growth from the platform. Coeptis expects this figure to multiply significantly as it engages in additional contracts with prospective clients.
Dave Mehalick, President and CEO of Coeptis, stated that the enthusiastic uptake of the NexGenAI marketing platform highlights the power of AI-driven capabilities. He affirmed the company's vision to innovate and lead in highly competitive sectors. Coeptis is focused on a rapid rollout of its platform throughout 2025 to enhance customer engagement and improve marketing strategies.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.